Drug development

eBook cover
#Antibody-based therapeutics #Drug development #Monoclonal antibodies

Efficiently develop antibody-based therapeutics

In the Quality by Design (QbD) approach to antibody-based therapeutics development, stability characterisation —the probability of a protein unfolding or denaturing— is performed to ensure that structure and function are preserved throughout development and manufacturing.  Antibodies are affected by many factors along their journey to become therapeutics. Read More

#Resources

#Cancer research #Cancer Research Horizons #Cancer Research UK #Drug development #Drug discovery #Oncology

New horizon for cancer innovation

Listen to this article on the DDW podcast: Earlier this year, Cancer Research UK (CRUK) launched its innovation engine, Cancer Research Horizons, to streamline drug discovery through the combination of its commercial and therapeutics teams. Reece Armstrong sits down with Cancer Research Horizons’ Chief Business Officer,… Read More

#Cancer Research #Exclusive Content

Jigsaw puzzle of the brain
#Alzheimer's #Antibody #Clinical trial #Cognitive impairment #Drug development #Drug discovery #Phase III trial

New Alzheimer’s treatment reduces decline in Phase III trial

A new Alzheimer’s disease (AD) treatment has been shown to reduce clinical decline in mild cognitive impairment (MCI) due to AD and mild AD with confirmed presence of amyloid pathology in the brain.  Eisai and Biogen’s anti-amyloid beta (Aβ) protofibril antibody lecanemab met the primary endpoint and… Read More

#News

#Drug development #Microfluidics #Organ-on-a-chip #Tissue chips

Using microfluidics in drug discovery

Download this 24-page DDW eBook, sponsored by Emulate, to learn about: How microfluidics is fuelling innovation in drug discovery A detailed look at the organ-on-a-chip sector How human tissue chips are helping advance our understanding of biology Download now. Read More

#DDW eBooks #Intelligence

#Biopharmaceuticals #Drug development #eBook #LC-MS

eBook – LC-MS Analysis for (Bio)pharmaceutical Research

This is the seventh eBook of the Hamilton series “LC-MS Analysis for (Bio)pharmaceutical Research”. This ebook covers: The role of LC-MS in the drug development process The drivers behind the need for LC-MS sample prep automation in biopharma The modules and full liquid handling automation solutions that Hamilton offers… Read More

#News

#Biopharmaceuticals #Drug development #Liquid handling #Research

LC-MS Analysis for (Bio)pharmaceutical Research

In the seventh eBook of the Hamilton series “LC-MS Analysis for (Bio)pharmaceutical Research”, we discuss: The role of LC-MS in the drug development process The drivers behind the need for LC-MS sample prep automation in biopharma The modules and full liquid handling automation solutions that Hamilton offers for LC-MS… Read More

#Intelligence #Resources

Chinese flag
#Biotechnology #Drug development #Drug discovery #Podcast

Podcast: China’s opportunities for global drug discovery breakthroughs

This is the latest episode of the free DDW podcast, “China’s opportunities for global drug discovery breakthroughs”. It covers three articles written for Volume 22, Issue 4 – Fall 2021 of DDW, narrated by DDW Multimedia Editor Megan Thomas. They are called “Is China entering a new phase for… Read More

#News

#Clinical trials #Drug development #Opinion #Patient centricity #Public health

What can patients do to give input into clinical trial design? 

Business and profitability remain unquestionably important in the drug discovery community. However, the industry’s overarching goal of public health and the betterment of society have never been more apparent than in the aftermath of the pandemic and when observing the heights scientists reached through determination and collaboration in the… Read More

#Exclusive Content #Opinion

A clinical trial
#APAC #Clinical research #Clinical trial design #Clinical trials #Drug development

Cytel hopes to accelerate drug development in APAC region

Cytel has expanded its operations into the Asia-Pacific region (APAC), with hopes of optimising clinical trial design in the area. Cytel works with its clients on various aspects of clinical trials, including statistical design, implementation and regulatory acceptance, with the aim of helping them reduce costs, shorten timelines, and better… Read More

#News

#Advanced Therapies #Biopharmaceuticals #Drug development

Leveraging education to close the advanced therapy talent gap 

Tony Khoury, Executive Vice President of Project Farma and Anshul Mangal, President & General Counsel of Project Farma, share how the industry is leveraging stronger education programmes to close the advanced therapy talent gap.  The cell and gene therapy industry has experienced exponential growth in the last three years… Read More

#Exclusive Content

San Diego skyline
#BioLabs #Charles River #Drug development #Drug discovery

Charles River expands contract vivarium space on West Coast

Charles River Laboratories has added five new Charles River Accelerator and Development Lab (CRADL) locations in California and Washington.  CRADL provides flexible, turnkey vivarium rental space supported by Charles River’s technical and veterinary support expertise in key biohubs. This allows clients to start new projects, accelerating the early stage… Read More

#Business & Investment #News

Vials for medical research
#Antibodies #Biomedical research #Drug development #Drug discovery #In vitro

New anti-evolocumab antibodies could aid drug development

Bio-Rad Laboratories has introduced a range of type 1 antibodies that inhibit the binding of evolocumab (Repatha) to its target, human proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that has been shown to play a key role in the regulation of cholesterol levels.  These sequence-defined, recombinant antibodies are… Read More

#News

SARS-CoV-2 virus particles
#Antibodies #Biomarkers #Clinical trials #Coronavirus #Covid-19 #Drug development #SARS-CoV-2

SARS-CoV-2 antigen levels could predict patient outcomes

The amount of SARS-CoV-2 antibodies in the blood of patients hospitalised with Covid-19 could be used to predict illness severity and other clinical outcomes.  A new study, published in the Annals of Internal Medicine, shows that higher levels of viral antigen in the blood, which… Read More

#Covid-19 #News

#Drug development #Immunology / Virology & Vaccines #Lyme Disease #Pfizer

Pfizer launches Phase III trial for Lyme disease vaccine  

Pfizer has launched a Phase III clinical trial of a vaccine to protect people against Lyme disease, in collaboration with pharmaceutical company Valneva.   The Vaccine Against Lyme for Outdoor Recreationists (VALOR) trial will investigate the efficacy, safety and immunogenicity of Pfizer and Valneva’s Lyme disease vaccine… Read More

#News

Scientist looking through microscope
#Assay #Biologics / Biotechnology #Biopharma #Drug development #Ingredients / APIs / Fine chemicals

Addressing the challenge of salt forms in drug discovery

Listen to this article on the DDW Podcast: Some 5% of commercially available research compounds are sold as salt forms. These can have better properties than their parents, including preferable stability, solubility, bioavailability, and manufacturability. By selecting the correct salt form for an assay or as a… Read More

#Exclusive Content #Opinion

#Biopharma #Biotechnology #CDMO #Drug development

Why project management holds the key to efficient drug development

Listen to this article on the DDW Podcast: Ian Hollingsworth, Associate Director of product development at Boyds, the global drug development consultancy, explains the benefits to the drug development lifecycle of building strong partnerships with external consultants, and when and how to get the best from them. Everyone can… Read More

#Exclusive Content